A new market research report on the Global Vital
Organs Support Systems and Medical Bionics market has introduced by KD
Market Insights. The report is dedicated to in-depth industry analysis of
the global Vital Organs Support Systems and Medical Bionics market. The Global Vital Organs Support Systems and
Medical Bionics analysis is broken down on
different segmentation levels including Market By Product, By End User.
The global vital organs support systems and medical
bionics market size in 2017 is $28,169 million, and is
projected to reach $59,412 million by 2025, growing at a CAGR
of 9.9% from 2018 to 2025. An artificial organ is an
engineered device or tissue that is implanted or integrated into a human,
interfacing with living tissue. Medical bionics, also known as biomedical
implants, are artificial addition to the body. These artificial implants mimic
the function of the lost or nonfunctional body part.
The vital organs support systems and medical bionics market is
expected to exhibit significant growth during the forecast period due to rise
in geriatric population, scarcity of donor organs, technological advancements
in the artificial organ sector, and increase in R&D expenditure. In
addition, rise in number of patients suffering from chronic diseases drives the
market growth. However, high cost of artificial organs and stringent approval
process are projected to impede growth of the vital organs support systems and
medical bionics market. On the contrary, application of advanced biomaterials
in artificial organs and lucrative opportunities in emerging economies are
expected to provide significant prospects for the manufacturers in the
industry.
The
global vital organs support systems and medical bionics market is
segmented based on product, end user, and region. Depending on product, the
market is categorized into vital organs support systems and medical bionics.
The vital organs support systems segment is further divided into artificial
heart, artificial kidney, artificial pancreas, artificial urinary bladder,
artificial lungs, and artificial liver. The medical bionics segment is
subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics,
and neural bionics. Depending on end user, the market is segregated into
hospitals, ambulatory surgical centers, and others. Region wise, it is studied
across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
-
This report provides a detailed quantitative analysis of the current market
trends and future estimations from 2018 to 2025, which assists to identify the
prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product
Vital
organs support systems
- - Artificial Heart
- - Artificial Kidney
- - Artificial Pancreas
- - Artificial Urinary Bladder
- - Artificial Lungs
- - Artificial Liver
Medical Bionics
- - Bionic Eye
- - Ear Bionics
- - - - Cochlear Implants
- - - - Bone Anchored Hearing Systems
- - - - Auditory Brainstem Implants
- - Orthopedic Bionics
- - - - Upper limb
- - - - Lower limb
- - - - - - Bionic Knee
- - - - - - Bionic Feet
- - - - Exoskeleton
- - - - Electrical Bone Growth Stimulators
- - - - - - Non-Invasive Bone Growth Stimulators
- - - - - - Invasive Bone Growth Stimulators
- - Cardiac Bionics
- - - - Pacemaker
- - - - - - Implantable Pacemaker
- - - - - - External Pacemaker
- - - - Ventricular Assist Device
- - - - - - Left Ventricular Assist Device (LVAD)
- - - - - - Right Ventricular Assist Device (RVAD)
- - - - - - Biventricular Assist Device (BIVAD)
- - - - Artificial Heart Valves
- - - - - - Mechanical Heart Valves
- - - - - - Tissue Heart Valves
- - Neural Bionics
- - - - Internal Neurostimulators
- - - - - - Deep Brain Stimulators (DBS)
- - - - - - Sacral Nerve Stimulators (SNS)
- - - - - - Vagus Nerve Stimulators (VNS)
- - - - - - Spinal Cord Stimulators (SCS)
- - - - - - Other Neurostimulators
- - External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
- - Artificial Heart
- - Artificial Kidney
- - Artificial Pancreas
- - Artificial Urinary Bladder
- - Artificial Lungs
- - Artificial Liver
Medical Bionics
- - Bionic Eye
- - Ear Bionics
- - - - Cochlear Implants
- - - - Bone Anchored Hearing Systems
- - - - Auditory Brainstem Implants
- - Orthopedic Bionics
- - - - Upper limb
- - - - Lower limb
- - - - - - Bionic Knee
- - - - - - Bionic Feet
- - - - Exoskeleton
- - - - Electrical Bone Growth Stimulators
- - - - - - Non-Invasive Bone Growth Stimulators
- - - - - - Invasive Bone Growth Stimulators
- - Cardiac Bionics
- - - - Pacemaker
- - - - - - Implantable Pacemaker
- - - - - - External Pacemaker
- - - - Ventricular Assist Device
- - - - - - Left Ventricular Assist Device (LVAD)
- - - - - - Right Ventricular Assist Device (RVAD)
- - - - - - Biventricular Assist Device (BIVAD)
- - - - Artificial Heart Valves
- - - - - - Mechanical Heart Valves
- - - - - - Tissue Heart Valves
- - Neural Bionics
- - - - Internal Neurostimulators
- - - - - - Deep Brain Stimulators (DBS)
- - - - - - Sacral Nerve Stimulators (SNS)
- - - - - - Vagus Nerve Stimulators (VNS)
- - - - - - Spinal Cord Stimulators (SCS)
- - - - - - Other Neurostimulators
- - External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
By End User
-
Hospitals
- Ambulatory Surgical Centers
- Others
- Ambulatory Surgical Centers
- Others
By Region
North
America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Australia
- Japan
- India
- China
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Australia
- Japan
- India
- China
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
-
Abiomed, Inc.
- Abbott Laboratories
- Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
- Baxter International Inc.
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Jarvik Heart, Inc.
- Medtronic Plc.
- Össur Americas, Inc.
- Second Sight Medical Products, Inc.
- SynCardia Systems LLC
- Abbott Laboratories
- Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
- Baxter International Inc.
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Jarvik Heart, Inc.
- Medtronic Plc.
- Össur Americas, Inc.
- Second Sight Medical Products, Inc.
- SynCardia Systems LLC
Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/vital-organs-support-systems-and-medical-bionics-market
Table of Content
CHAPTER 1: INTRODUCTION
1.1.
Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1.
Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.
CXO perspective
2.2. Key findings
2.2. Key findings
2.2.1.
Top impacting factors
2.2.2. Top investment pockets
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1.
Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1.
Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3.
Pricing Analysis
3.3.1.
Pricing Analysis, By Region, 2018 & 2025
3.4.
Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1.
Case Study 01
3.9.
Market dynamics
3.9.1.
Drivers
3.9.1.1.
Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2.
Restraints
3.9.2.1.
High cost of treatment
3.9.2.2. Stringent approval process
3.9.2.2. Stringent approval process
3.9.3.
Opportunities
3.9.3.1.
Lucrative opportunities in emerging economies
CHAPTER 4: VITAL ORGANS SUPPORT
SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1.
Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1.
Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2. Market size and forecast, by type
4.3.2.1.
Artificial Heart
4.3.2.1.1.
Market size and forecast
4.3.2.2.
Artificial Kidney
4.3.2.2.1.
Market size and forecast
4.3.2.3.
Artificial Pancreas
4.3.2.3.1.
Market size and forecast
4.3.2.4.
Artificial Urinary Bladder
4.3.2.4.1.
Market size and forecast
4.3.2.5.
Artificial Lungs
4.3.2.5.1.
Market size and forecast
4.3.2.6.
Artificial Liver
4.3.2.6.1.
Market size and forecast
4.3.3.
Market size and forecast, by region
4.3.4. Market analysis by country
4.3.4. Market analysis by country
4.4.
Medical Bionics
4.4.1.
Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2. Market size and forecast, by type
4.4.2.1.
Bionic Eye
4.4.2.1.1.
Market size and forecast
4.4.2.2.
Ear Bionics
4.4.2.2.1.
Market size and forecast, by type
4.4.2.2.1.1.1.
Cochlear Implants
4.4.2.2.1.1.1.1
Market size and forecast
4.4.2.2.1.1.2.
Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1.
Market size and forecast
4.4.2.2.1.1.3.
Auditory Brainstem Implants
4.4.2.2.1.1.3.1
Market size and forecast
4.4.2.3.
Orthopedic Bionics
4.4.2.3.1.
Market size and forecast, by type
4.4.2.3.1.1.1.
Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1.
Bionic Knee
4.4.2.3.1.1.4.1.1.
Market size and forecast
4.4.2.3.1.1.4.2.
Bionic Feet
4.4.2.3.1.1.4.2.1.
Market size and forecast
4.4.2.3.1.1.5.
Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1.
Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1.
Market size and forecast
4.4.2.3.1.1.8.2.
Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1.
Market size and forecast
4.4.2.4.
Cardiac Bionics
4.4.2.4.1.
Market size and forecast, by type
4.4.2.4.1.1.1.
Pacemaker
4.4.2.4.1.1.1.1
Market size and forecast, by type
4.4.2.4.1.1.2.
Implantable Pacemaker
4.4.2.4.1.1.2.1.
Market size and forecast
4.4.2.4.1.1.3.
External pacemaker
4.4.2.4.1.1.3.1
Market size and forecast
4.4.2.4.1.1.3.
Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4.
Market size and forecast, by type
4.4.2.4.1.1.4.1.
Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1.
Market size and forecast
4.4.2.4.1.1.4.2.
Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1.
Market size and forecast
4.4.2.4.1.1.4.3.
Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1.
Market size and forecast
4.4.2.4.1.1.5.
Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1.
Mechanical Heart Valves
4.4.2.4.1.1.6.1.1.
Market size and forecast
4.4.2.4.1.1.6.2.
Tissue Heart Valves
4.4.2.4.1.1.6.2.1.
Market size and forecast
4.4.2.5.
Neural Bionics
4.4.2.5.1.
Market size and forecast, by type
4.4.2.5.1.1.
Internal Neurostimulators
4.4.2.5.1.1.1.
Market size and forecast, by type
4.4.2.5.1.1.1.1.
Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1.
Market size and forecast
4.4.2.5.1.1.1.2.
Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1.
Market size and forecast
4.4.2.5.1.1.1.3.
Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1.
Market size and forecast
4.4.2.5.1.1.1.4.
Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1.
Market size and forecast
4.4.2.5.1.1.1.5.
Other Neurostimulators
4.4.2.5.1.1.1.5.1.
Market size and forecast
4.4.2.5.1.2.
External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1.
Market size and forecast
4.4.3.
Market size and forecast, by region
4.4.4. Market analysis by country
4.4.4. Market analysis by country
CHAPTER 5: VITAL ORGANS SUPPORT
SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1.
Overview
5.2. Market size and forecast
5.3. Hospitals
5.2. Market size and forecast
5.3. Hospitals
5.3.1.
Market size and forecast, by region
5.3.2. Market analysis by country
5.3.2. Market analysis by country
5.4.
Ambulatory surgical centers (ASCs)
5.4.1.
Market size and forecast, by region
5.4.2. Market analysis by country
5.4.2. Market analysis by country
5.5.
Others
5.5.1.
Market size and forecast, by region
5.5.2. Market analysis by country
5.5.2. Market analysis by country
Continue @...
About Us:
KD Market
Insights offers a
comprehensive database of syndicated research studies, customized reports, and
consulting services. These reports are created to help in making smart, instant
and crucial decisions based on extensive and in-depth quantitative information,
supported by extensive analysis and industry insights. Our dedicated in-house
team ensures the reports satisfy the requirement of the client. We aim at
providing value service to our clients. Our reports are backed by extensive
industry coverage and is made sure to give importance to the specific needs of
our clients. The main idea is to enable our clients to make an informed
decision, by keeping them and ourselves up to date with the latest trends in
the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon